Skip to content

斯特瓦纳托集团

US · STVN #2012 按市值排名 上市于 2021
18.90 -0.35 -1.82%
实时 - 追踪5344个代码 - 心跳于431秒前 · 2026-10-16 20:02

✦ 量化合理价值 计算方式说明

接近合理价值
10.72 合理价值 ≈ 19.91 29.11
  • 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为10.72-29.11。
  • 当前价格比按平均倍数计算的合理价值(19.91)低5.1%。

估值 各估值倍数与自身5年区间的对比

市净率 3.13 低于历史水平 第30百分位
5年平均 3.61 · 在Medical Instruments & Supplies中排名第29/51
市盈率 36.20 处于历史正常水平 第47百分位
5年平均 34.81 · 前瞻 28.10 · 在Medical Instruments & Supplies中排名第16/27
市销率 3.94 低于历史水平 第25百分位
5年平均 4.54 · 前瞻 3.66 · 在Medical Instruments & Supplies中排名第36/51

同业对比 Medical Instruments & Supplies

公司 市值 市盈率(TTM) 市净率 股息率
斯特瓦纳托集团 (STVN) 5.16B 34.36 2.97 0.33%
Intuitive Surgical (ISRG) 150.74B 48.93 8.30 0.00%
Becton Dickinson & Co (BDX) 52.23B 57.93 2.14 2.19%
ResMed (RMD) 33.61B 22.91 5.10 1.00%
Alcon (ALC) 31.99B 50.52 1.48 0.53%
Medline (MDLN) 31.55B 68.24 2.73 0.00%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值22.27 经济护城河Narrow 不确定性Medium

当前股价低于晨星合理价值估算17.8%。

合理价值

Stevanato Group SpA earns a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 10% discount to our quantitative fair value estimate of $22.27 per share; however, some caution is warranted due to this estimate's medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

We need more explanatory data to elaborate on this stock's star rating. We strive to explain the factors driving every rating we assign; however, this is not yet possible for a small fraction of our coverage universe.

经济护城河

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

作者:Quantitative Equity Report

报价时间 2026-10-16 20:02:25 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

斯特瓦纳托集团 讨论区 0 条评论

发表评论